Wolverine Trading, LLC Amarin Corp Plcuk Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$0.57 - $0.8 $3,761 - $5,280	-6,600 Reduced 17.84%	30,400 $19,000
Q2 2024 Aug 14, 2024	BUY	$0.63 - $1.07 $23,310 - $39,590	37,000 New	37,000 $25,000
Q4 2023 Feb 14, 2024	BUY	$0.66 - $0.91 $29,304 - $40,404	44,400 New	44,400 $38,000
Q4 2022 Feb 14, 2023	BUY	$1.07 - $1.34 $114,169 - $142,978	106,700 Added 330.34%	139,000 $168,000
Q3 2022 Nov 14, 2022	SELL	$1.09 - $1.67 $24,089 - $36,907	-22,100 Reduced 40.63%	32,300 $36,000
Q2 2022 Aug 15, 2022	SELL	$1.13 - $3.69 $29,718 - $97,047	-26,300 Reduced 32.59%	54,400 $99,000
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $229,995 - $301,011	80,700 New	80,700 $263,000
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $511,596 - $817,922	-157,900 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.94 - $5.84 $622,126 - $922,136	157,900 New	157,900 $812,000
Q2 2021 Aug 06, 2021	SELL	$4.26 - $6.5 $762,114 - $1.16 Million	-178,900 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$5.03 - $8.8 $181,080 - $316,800	-36,000 Reduced 16.75%	178,900 $1.14 Million
Q4 2020 Feb 12, 2021	BUY	$4.04 - $5.31 $174,932 - $229,922	43,300 Added 25.23%	214,900 $1.12 Million
Q3 2020 Nov 13, 2020	BUY	$3.64 - $7.76 $173,992 - $370,928	47,800 Added 38.61%	171,600 $693,000
Q2 2020 Aug 13, 2020	SELL	$4.78 - $8.26 $812,122 - $1.4 Million	-169,900 Reduced 57.85%	123,800 $832,000
Q1 2020 May 11, 2020	BUY	$4.0 - $21.53 $71,200 - $383,234	17,800 Added 6.45%	293,700 $3.99 Million
Q4 2019 Feb 12, 2020	SELL	$13.94 - $24.12 $1.1 Million - $1.9 Million	-78,900 Reduced 22.24%	275,900 $5.8 Million
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $1.5 Million - $2.5 Million	108,000 Added 43.76%	354,800 $5.38 Million
Q2 2019 Aug 20, 2019	SELL	$16.27 - $20.51 $2.09 Million - $2.63 Million	-128,200 Reduced 34.19%	246,800 $4.79 Million
Q1 2019 May 15, 2019	SELL	$12.61 - $22.33 $919,269 - $1.63 Million	-72,900 Reduced 16.28%	375,000 $7.79 Million
Q4 2018 Feb 14, 2019	SELL	$12.41 - $22.98 $1.2 Million - $2.22 Million	-96,400 Reduced 17.71%	447,900 $5.93 Million
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $918,750 - $6.1 Million	375,000 Added 221.5%	544,300 $8.86 Million
Q1 2018 May 15, 2018	BUY	$2.99 - $4.44 $506,207 - $751,692	169,300 New	169,300 $510,000
Q4 2017 Feb 14, 2018	SELL	$3.06 - $4.09 $249,696 - $333,744	-81,600 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$3.03 - $3.72 $247,247 - $303,552	81,600	81,600 $286,000

Others Institutions Holding AMRN

# of Institutions

177

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

Sarissa Capital Management LP Greenwich, CT

24.9M
Shares

$13.7 Million
3.89% of portfolio
Kynam Capital Management, LP Princeton, NJ

12.4M
Shares

$6.83 Million
0.64% of portfolio
Eversept Partners, LP New York, NY

3.31M
Shares

$1.82 Million
0.16% of portfolio
Morgan Stanley New York, NY

2.55M
Shares

$1.4 Million
0.0% of portfolio
Scp Investment, LP

2.5M
Shares

$1.38 Million
1.16% of portfolio

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account